Related Experiment Videos
Multiple effects of calcium entry blockers on renal function in hypertension
Hypertension (Dallas, Tex. : 1979)
|August 1, 1987
Summary
Calcium entry blockers impact kidney function by altering sodium excretion and renal hemodynamics. These drugs are effective for hypertension, potentially by correcting calcium metabolism defects.
Area of Science:
- Nephrology
- Pharmacology
- Cardiovascular Medicine
Background:
- Characterizing renal effects of calcium entry blockers is complex due to altered regulatory functions from inhibiting calcium cellular influx.
- Calcium blockers' renal vasodilation and GFR increase depend on pre-existing vascular tone.
- Increases in sodium excretion may occur independently of renal hemodynamic changes.
Purpose of the Study:
- To elucidate the mechanisms by which calcium entry blockers affect renal sodium excretion.
- To investigate the role of calcium blockers in managing essential hypertension and maintaining renal function.
- To explore the potential link between calcium metabolism alterations and calcium blocker efficacy in hypertensive patients.
Main Methods:
- In vitro studies examining effects on renin secretion and prostaglandin synthesis.
- Analysis of long-term administration data for essential hypertension treatment.
- Review of reports on calcium blocker efficacy in specific hypertensive subgroups.
Main Results:
- In vitro blockade of calcium entry enhances renin secretion and decreases prostaglandin synthesis.
- Long-term administration of calcium blockers is effective for essential hypertension with normal renal function maintenance.
- A subgroup of hypertensive patients with calcium metabolism alterations shows particular responsiveness to calcium blockers.
Conclusions:
- Calcium blockers may increase sodium excretion via renal blood flow redistribution, inhibited tubuloglomerular feedback, or direct tubular effects.
- The dissociation between renin and prostaglandin effects observed in vitro is not apparent during long-term administration.
- Further research is needed to confirm if calcium blockers correct underlying calcium cellular kinetics defects in hypertension.